Thomas (Tom) Hartman was appointed President & CEO of the International Society for Pharmaceutical Engineering in June 2020. Prior to his appointment, Mr. Hartman was Vice President of GMP Operations, Biopharmaceutical Development & Supply for GSK. His extensive executive experience includes all aspects of CMC clinical supply chain management for drug substance and drug product for the GSK’s biopharmaceutical portfolio, and the manufacturing and supply of viral vector enabling GSK’s leading-edge cell & gene therapy platform. Experienced in critical CMC functions including cell banking, materials management, manufacturing of product specific modalities including microbial and mammalian expression systems, and support functions including facility monitoring, engineering, capital project management, validation, quality control/stability, distribution, recall management, and with a strong regulatory perspective. He also has extensive experience in negotiating supply contracts with multiple international CMO/CRO’s. Prior to joining GSK in 2001, he held multiple engineering and operations roles with a major US based chemical manufacturer, including a five-year expatriate role in the Netherlands, culminating with responsibilities as head of engineering for one of the largest chemical facilities in the US. Tom has effectively conducted business in multiple regions including the US, UK, Europe, Asia, & South America. Tom has been a member of ISPE since 2001, and served nearly 7 years on ISPE’s Board of Directors prior to being appointed to his current role.